Physician profile
Daniel W Narowitz
NPI 1922686872
$12,433.84
in general payments reported to CMS, 2019-2025
17 companies · $8,575 in 2025
The $8,575 reported for 2025 was more than what 97% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $53.41 · 2024: $3,806 · 2025: $8,575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,988 · Food and Beverage: $4,874 · Education: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,988.01 |
| Food and Beverage | $4,874.35 |
| Education | $571.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,033.82 | 2024-2025 | Hoffmann, Ortholoc 3di, Infinity Adaptis |
| Paragon 28, INC. | $2,890.06 | 2025 | Portfolio, Mtp |
| Linvatec Corporation | $2,067.62 | 2024-2025 | Biobrace 23mm, Neospan, Ibs |
| Convatec INC. | $1,607.09 | 2024-2025 | |
| Arthrex, INC. | $743.55 | 2024 | |
| Medical Device Business Services, INC. | $571.48 | 2024-2025 | Actis |
| Elite Orthopedics, LLC | $305.73 | 2024-2025 | |
| Acumed LLC | $296.86 | 2024-2025 | Acumed, Acumed, Osteomed |
| Koya Medical, INC. | $149.12 | 2024 | Dayspring, Koya Medical |
| Kuros Biosciences USA, INC | $138.52 | 2025 | Magnetos |
| Tactile Systems Technology INC | $125.53 | 2025 | Nimbl, Flexitouch Plus |
| Acera Surgical, INC. | $125.15 | 2024 | Restrata Wound Matrix |
| Treace Medical Concepts, INC. | $106.37 | 2025 | |
| Solventum Corporation | $98.39 | 2024 | Activ.A.C. |
| Reprise Biomedical, INC. | $89.84 | 2025 | Miro3d |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $67.98 | 2023-2024 | |
| Paratek Pharmaceuticals, INC. | $16.73 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Narowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.